Use of a cytokine regulatory agent to treat rheumatoid arthritis

Details Use of a cytokine regulatory agent to treat rheumatoid arthritis Use of a cytokine regulatory agent to treat rheumatoid arthritis

1996-09-27

1998-04-21

Tsang, Cecilia J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 16, 514 17, 514 18, 530317, 530322, 530328, 530329, 530330, A61K 3800, C07K 500, C07K 700, C07K 1700

Patent

active

057417741

ABSTRACT:
The present invention relates to the use of a cytokine regulatory agent to reduce the severity of rheumatoid arthritis.

REFERENCES:
patent: 5420109 (1995-05-01), Suto et al.
patent: 5457129 (1995-10-01), Aggarwal et al.
Arai et al. Cytokines:Coordinators of immune and inflammatory responses. Annu. Rev. Biochem. 59: 783-836 Jun. 1990.
Wooley et al., "Influence of a Recombinant Human Soluble Tumor Necrosis Factor Receptor FC Fusion Protein on Type II Collagen-Induced Arthritis in Mice," J. Immunol. 151:6602-6607 (1993).
Wooley et al., "The Effect of an Interleukin-1 Receptor Antagonist Protein on Type II Collagen-induced Arthritis and Antigen-induced Arthritis in Mice," Arthr. Rheum. 36:1305-1314 (1993).

Affiliated with

Also associated with

Rating

Use of a cytokine regulatory agent to treat rheumatoid arthritis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of a cytokine regulatory agent to treat rheumatoid arthritis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of a cytokine regulatory agent to treat rheumatoid arthritis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2057562